A Non-Interventional PASS of Ruxolitinib in Myelofibrosis
Research type
Research Study
Full title
A Non-Interventional Long-term Safety Study of Ruxolitinib in Myelofibrosis
IRAS ID
120451
Contact name
Jonathan Lambert
Contact email
Sponsor organisation
Novartis Pharma AG
REC name
West of Scotland REC 5
REC reference
13/WS/0034
Date of REC Opinion
7 Feb 2013
REC opinion
Favourable Opinion